CDH1 and cancer: In summary, these findings have mechanistic implications for human cancers with co-existing APC and CDH1 loss of function, as the enhanced β-catenin function and invasive phenotypes that arise point to the important tumour suppressor function of both the protein binding functions of intact E-cadherin.